Close Menu

Shifts at Pfizer

Pfizer is closing a research and development site in the UK at Sandwich, Kent, notes In the Pipeline's Derek Lowe. About 2,400 people work at the site and Pfizer says that it hopes to transfer a few those positions to other sites. "Although the company says that perhaps several hundred may find positions elsewhere, this is a major blow to drug discovery operations in the UK," Lowe says.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Reuters reports that Germany is seeking to sequence 5 percent of patient samples that test positive for SARS-CoV-2.

The publisher of the Science family of journals will allow some authors to place peer-reviewed versions of their papers into publicly accessible repositories.

23andMe and Medscape say primary care physicians are increasingly more comfortable with discussing direct-to-consumer genetic testing results.

In Science this week: analysis of genome-wide association studies of chronic kidney disease, and more.